Skip to main content
CX
NYSE Manufacturing

CEMEX Q2 EBITDA Tops $1B, Full-Year Growth Outlook Lifted to 16–17%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$12.8
Mkt Cap
$19.273B
52W Low
$7.695
52W High
$13.67
52W Position info
66% above low
Off High info
6.4% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CX sits 66% above its 52-week low of $7.695.

Summary

CEMEX reported Q2 2026 EBITDA of $1.018 billion, up 24% year-over-year, and raised its full-year EBITDA growth guidance to 16–17%. Record free cash flow of $637 million and an increased cost-savings target underscore the momentum of its transformation program.


Key Events · Earnings and Guidance · CX

  • Record Q2 EBITDA of $1.018B

    Consolidated EBITDA reached $1.018 billion, a 24% increase year-over-year, driven by Project Cutting Edge efficiencies and organic growth in most regions. EBITDA margin expanded 2.1 percentage points to 22.2%.

  • Full-Year EBITDA Guidance Raised to 16-17% Growth

    Management lifted its 2026 EBITDA growth outlook from high single digits to 16–17%, citing strong first-half performance and continued contributions from its cost-savings program.

  • Free Cash Flow Triples to $637M

    Free cash flow from operations surged to $637 million in Q2, up from $204 million a year ago, supported by improved working capital and lower interest payments.

  • Cost-Savings Target Increased by $75M

    The Project Cutting Edge savings target was raised to $475 million, with 80% of the original $400 million goal already achieved. Most new savings are expected in 2027 from procurement.


Analysis · CX · Manufacturing

A standout quarter saw EBITDA surge 24% to a record $1 billion, powered by cost efficiencies and a recovery in Mexico. With the transformation clearly accelerating, management raised its full-year EBITDA growth outlook from high single digits to 16–17%. Free cash flow tripled to $637 million, providing ample capacity for shareholder returns and debt reduction. The results beat expectations and signal that the company's turnaround is gaining real traction.

At the time of this filing, CX was trading at $12.80 on NYSE in the Manufacturing sector, with a market capitalization of approximately $19.3B. The 52-week trading range was $7.70 to $13.67. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CX - Latest Insights

CX
Jul 20, 2026, 9:26 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.00
Real-time Price: $13.07 info
Change: +$0.070 (+0.54%) info
Market Cap: $19.273B info
CX
Jun 26, 2026, 5:01 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $12.09
Real-time Price: $13.07 info
Change: +$0.980 (+8%) info
Market Cap: $19.273B info
CX
Jun 11, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.70
Real-time Price: $13.07 info
Change: +$0.370 (+3%) info
Market Cap: $19.273B info
CX
Jun 05, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.47
Real-time Price: $13.07 info
Change: +$0.600 (+5%) info
Market Cap: $19.273B info
CX
Jun 05, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $12.47
Real-time Price: $13.07 info
Change: +$0.600 (+5%) info
Market Cap: $19.273B info